Activity of voriconazole against corneal isolates of Scedosporium apiospermum

Cornea

Volumn 22, Issue 1, 2003, Pages 33-36

  Shah, Kekul B ^a   Wu, Tzu G ^a   Wilhelmus, Kirk R ^a,b   Jones, Dan B ^a  

^a CULLEN EYE INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Antifungal drugs; Fungal keratis; Scedosporium apiospermum

Indexed keywords

AMPHOTERICIN B; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; NATAMYCIN; POLYENE ANTIBIOTIC AGENT; VORICONAZOLE;

ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CASE REPORT; CORNEA; FEMALE; HUMAN; KERATITIS; KERATOMYCOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIUM APIOSPERMUM;

ANTIFUNGAL AGENTS; CORNEA; EYE INFECTIONS, FUNGAL; HUMANS; KERATITIS; MADUROMYCOSIS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PYRIMIDINES; SCEDOSPORIUM; TREATMENT OUTCOME; TRIAZOLES;

EID: 0037226341     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200301000-00008     Document Type: Article

References (24)

1. Behrens-Baumann W, Ruchel R, Mycoses of the eye and its adnexa. In Developments in Ophthalmology, Vol. 32. Magdeberg: S. Karger, 1999:37-41.
2. Bloom PA, Laidlaw DAH, Easty DL, et al. Treatment failure in a case of fungal keratitis caused by Pseudallescheria boydii. Br J Ophthalmol 1992;76:367-8.
3. Ksiazek SM, Morris DA, Mandelbaum S, et al. Fungal panophthalmitis secondary to Scedosporium apiospermum (Pseudallescheria boydii) keratitis. Am J Ophthalmol 1994;188:531-3.
4. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidiumforming Filamentous Fungi. Proposed Standard M38-P. Villanova, PA: National Committee for Clinical Laboratory Standards, 1998.
5. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature. Mycopathologia 2001;150:101-5.
6. Sabo JA, Abdel-Rahmna SM. Voriconazole: A new triazole antifungal. Ann Pharmacother 2000;34:1032-43.
7. Johnson EM, Szekely A, Warnock DW. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998;42:741-5.
8. Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, et al. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999;43:149-51.
9. Carrillo AJ, Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001;45:2151-3.
10. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001;39:954-8.
11. Meletiadis J, Meis F, Mouton JW, et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002;46:62-8.
12. Venugopal PL, Venugopal TL, Gomathi A, et al. Mycotic keratitis in Madras. Indian J Pathol Microbiol 1989;32:190-7.
13. Sundaram BM, Badrinath S, Subramanian S. Studies in mycotic keratitis. Mycoses 1989;32:568-72.
14. Chander J, Sharma A. Prevalence of fungal corneal ulcers in northern India. Infection 1994;22:207-9.
15. D'Hordy K, Pargs-Van Gunderdeuren R, Fets B. Fungal keratitis caused by Pseudallescheria boydii. Bull Soc Beige Ophtalmol 2000;277:53-6.
16. Sridar MS, Garg P, Bansal AK, et al. Fungal keratitis after LASIK. J Cataract Refract Surg 2000;26:613-5.
17. Rumelt S, Cohen I, Lefler E, et al. Corneal co-infection with S. apiospermum and S. aureus after sewage contaminated ocular injury. Cornea 2001;20:112-6.
18. Froumis NA, Mandino BJ, Glasgow BJ. Acanthamoeba keratitis associated with fungal keratitis. Am J Ophthalmol 2001;131:508-9.
19. Arthur S, Steed LL, Apple DJ, et al. Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. Antimicrob Agents Chemother 2001;39:2151-3.
20. Girmenia C, Luzi G, Monaco M, et al. Use of voriconazole in treatment of Scedosporium apiospermum infection: Case report. J Clin Microbiol 1998;36:1436-8.
21. Poza G, Montoya J, Redondo C, et al. Meningitis caused by Pseudallescheria boydii treated with voriconazole. Clin Infect Dis 2000;30:981-2.
22. Nesky MA, McDougal EC, Peacock JE Jr. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: Case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 2000;31:673-7.
23. Muñoz P, Marin M, Tornero P, et al. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 2000;31:1499-501.
24. Reis A, Suadmacher R, Tintelnot K, et al. Successful treatment of ocular invasive mold infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 2000;84:932-3.